Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Share this article Share this article WALTHAM, Mass., April 15, 2021 /PRNewswire/ -- Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, announced today that it has entered into a $15 million debt facility with Avenue Venture Opportunities Fund, L.P. ("Avenue Venture Fund"). "We are pleased to partner with Avenue Venture Fund and their team as we achieve some of the most significant milestones in our companys history. This non-dilu...
Elizabeth Holmberg Venture Opportunities Fund Venture Fund Lp Avenue Venture Fund Capital Group Third Pole Therapeutics Inc
Source: prnewswire.com